Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308398771> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W4308398771 abstract "<h3>Background</h3> Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TILs) has emerged as an additional treatment option for non-small cell lung cancer (NSCLC). However, the absence of predictive factors for therapeutic efficacy and successful expansion and lack of knowledge of changes in TILs characteristics during expansion are hurdles to the clinical introduction of TIL therapy. Herein, we report the characteristics of TILs and their changes during manufacturing. <h3>Methods</h3> 103 cases of NSCLC operational specimens were prospectively collected at the single institute. In the initial expansion (IE) step, lung cancer tissues were cut into 1 to 2-mm diameter fragments and expanded within 2 hours of surgery. In the rapid expansion (REP) step, post-IE TILs were cultured with allogeneic peripheral blood mononuclear cells, interleukin-2, and human anti-CD3 antibody. The memory subsets and PD-1 expression status of TILs were estimated via flow cytometry (CD3, CD4, CD8, CD45, CD45RA, CCR7, and PD-1). IFN-γ ELISA assay with TILs (4.0×10^5) and autologous cancer cells (1.0×10^5) was evaluated. We investigated clinicopathologic characteristics including the level of stromal TIL (sTIL) and tertiary lymphoid structures (TLS) in hematoxylin and eosin stained slides. <h3>Results</h3> The median IE cells per fragment were 2.5×10^5 (range 0.02 ~ 30.8×10^5), and the success rate of IE is 81.6% (84 of 103 cases, cut-off value of 0.8×10^5). The sTIL and IE cells per fragment showed positive correlation (Pearson’s r=0.215, p= 0.029). Increased TLS grades were associated with IE cells per fragment (Jonchheere-Terpstra test, p=0.008). Effector memory type was a major subset in both IE (n=39; CD8+, mean 72.4%; CD4+, mean 86.1%) and REP (n=29; CD8+, mean 85.6%; CD4+, mean 91.6%). Mean PD-1+ cells were 30.4% in IE (n=25) and 12.6% in REP (n=20). 75% (12 of 16) of the REP TIL cases showed a more than 2-fold increase of IFN-γ secretion against autologous cancer cells. Cases with less than 2-fold increased IFN-γ secretion showed higher PD-1+ cell proportion (n=2, 47.3%) in REP than cases with above 2-fold increase (n=6, 2.0%). Cases with higher IFN-γ fold change showed a decrease of PD-1+ cell proportion during IE to REP (n=3). <h3>Conclusions</h3> We successfully manufactured expanded TILs from NSCLC specimens for TIL therapy. The TLS and sTIL may be potential markers for the prediction of successful TIL expansion in NSCLC. Effector memory cells were the main subset of therapeutic TIL products. PD-1 expression was decreased during REP and it was associated with higher IFN-γ secretion against autologous cancer cells." @default.
- W4308398771 created "2022-11-11" @default.
- W4308398771 creator A5010518834 @default.
- W4308398771 creator A5032349144 @default.
- W4308398771 creator A5052960312 @default.
- W4308398771 creator A5090050510 @default.
- W4308398771 date "2022-11-01" @default.
- W4308398771 modified "2023-09-25" @default.
- W4308398771 title "249 Heterogeneity and changes of T-cell subset proportion during the expansion of tumor-infiltrating lymphocytes in non-small cell lung cancer" @default.
- W4308398771 doi "https://doi.org/10.1136/jitc-2022-sitc2022.0249" @default.
- W4308398771 hasPublicationYear "2022" @default.
- W4308398771 type Work @default.
- W4308398771 citedByCount "0" @default.
- W4308398771 crossrefType "proceedings-article" @default.
- W4308398771 hasAuthorship W4308398771A5010518834 @default.
- W4308398771 hasAuthorship W4308398771A5032349144 @default.
- W4308398771 hasAuthorship W4308398771A5052960312 @default.
- W4308398771 hasAuthorship W4308398771A5090050510 @default.
- W4308398771 hasBestOaLocation W43083987711 @default.
- W4308398771 hasConcept C114684123 @default.
- W4308398771 hasConcept C121608353 @default.
- W4308398771 hasConcept C125473707 @default.
- W4308398771 hasConcept C126322002 @default.
- W4308398771 hasConcept C142724271 @default.
- W4308398771 hasConcept C167672396 @default.
- W4308398771 hasConcept C203014093 @default.
- W4308398771 hasConcept C204232928 @default.
- W4308398771 hasConcept C2776090121 @default.
- W4308398771 hasConcept C2776256026 @default.
- W4308398771 hasConcept C2777701055 @default.
- W4308398771 hasConcept C2778326572 @default.
- W4308398771 hasConcept C502942594 @default.
- W4308398771 hasConcept C553184892 @default.
- W4308398771 hasConcept C71924100 @default.
- W4308398771 hasConcept C8891405 @default.
- W4308398771 hasConceptScore W4308398771C114684123 @default.
- W4308398771 hasConceptScore W4308398771C121608353 @default.
- W4308398771 hasConceptScore W4308398771C125473707 @default.
- W4308398771 hasConceptScore W4308398771C126322002 @default.
- W4308398771 hasConceptScore W4308398771C142724271 @default.
- W4308398771 hasConceptScore W4308398771C167672396 @default.
- W4308398771 hasConceptScore W4308398771C203014093 @default.
- W4308398771 hasConceptScore W4308398771C204232928 @default.
- W4308398771 hasConceptScore W4308398771C2776090121 @default.
- W4308398771 hasConceptScore W4308398771C2776256026 @default.
- W4308398771 hasConceptScore W4308398771C2777701055 @default.
- W4308398771 hasConceptScore W4308398771C2778326572 @default.
- W4308398771 hasConceptScore W4308398771C502942594 @default.
- W4308398771 hasConceptScore W4308398771C553184892 @default.
- W4308398771 hasConceptScore W4308398771C71924100 @default.
- W4308398771 hasConceptScore W4308398771C8891405 @default.
- W4308398771 hasLocation W43083987711 @default.
- W4308398771 hasOpenAccess W4308398771 @default.
- W4308398771 hasPrimaryLocation W43083987711 @default.
- W4308398771 hasRelatedWork W1525330868 @default.
- W4308398771 hasRelatedWork W1552542233 @default.
- W4308398771 hasRelatedWork W2000315532 @default.
- W4308398771 hasRelatedWork W2348095005 @default.
- W4308398771 hasRelatedWork W2355095363 @default.
- W4308398771 hasRelatedWork W2377467020 @default.
- W4308398771 hasRelatedWork W2387609598 @default.
- W4308398771 hasRelatedWork W2935834835 @default.
- W4308398771 hasRelatedWork W3104347469 @default.
- W4308398771 hasRelatedWork W95175456 @default.
- W4308398771 isParatext "false" @default.
- W4308398771 isRetracted "false" @default.
- W4308398771 workType "article" @default.